Clinical Trials Logo

BPH clinical trials

View clinical trials related to BPH.

Filter by:

NCT ID: NCT00199550 Completed - Clinical trials for Benign Prostatic Hyperplasia

Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)

Start date: May 2004
Phase: Phase 4
Study type: Interventional

This study will prospectively evaluate a new electrosurgical procedure (bipolar transurethral prostatectomy) in men with symptomatic benign prostatic hyperplasia.

NCT ID: NCT00154843 Completed - BPH Clinical Trials

A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation

Start date: March 2004
Phase: Phase 2
Study type: Interventional

Primary: To determine factors that affect absorption and serum levels of lycopene after supplementation. Secondary: 1. To evaluate general safety and tolerability of oral lycopene 15 or 30 mg per day for 12 weeks. 2. To determine lycopene effects on reducing serum levels of prostate specific antigen (PSA) and on relieving lower urinary tract symptoms (LUTS) in relation to prostate hypertrophy as evaluated by the International Prostate Symptom Score (I-PSS).

NCT ID: NCT00037141 Completed - Clinical trials for Benign Prostatic Hyperplasia

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

Start date: March 2002
Phase: Phase 1/Phase 2
Study type: Interventional

Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men will be enrolled in the study. Qualifying patients will receive one of three possible doses of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month, 3-months, and 6-months following treatment.